A simple algorithm to aid in the selection of appropriate disease modifying therapies (DMTs) reduces racial disparities in patients with relapsing multiple sclerosis (MS), early new research showed.
Plerixafor, a reversible CXCR4 antagonist, significantly increases the yield of CD34 + peripheral blood cells in randomized studies, thereby enabling more patients to proceed to autologous transplant.
What Is the Luhn Algorithm? The Math Behind Credit Card Transactions Find out how this simple algorithm from the 1960s catches your typos Jack Murtagh Tue, August 12, 2025 at 8:30 AM PDT 6 min read ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback